ロード中...
Beyond The Needle: Biotech’s Delivery Challenge
Finding new ways to administer biologics could lead to higher patient acceptance and lower costs, and prove crucial as biotech companies release products aimed at more prevalent diseases. Here’s a look at the emerging world of noninjectable biologics.
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioCommunications LLC
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564283/ https://ncbi.nlm.nih.gov/pubmed/23390391 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|